Long Term Inhibition by Estradiol or Progesterone of Melatonin Secretion After Administration of a Mammary Carcinogen, the Dimethyl Benz(a)anthracene, in Sprague-Dawley Female Rat; Inhibitory Effect of Melatonin on Mammary Carcinogenesis

[1]  J. Russo,et al.  Differentiation of the mammary gland and susceptibility to carcinogenesis , 2005, Breast Cancer Research and Treatment.

[2]  S. Hill,et al.  Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7,12-dimethylbenzanthracene-(DMBA)-induced mammary tumorigenesis , 2005, Journal of Neural Transmission.

[3]  M. Jimenez-Linan,et al.  Long-term Effects of the Mammary Carcinogen 7,12-Dimethylbenz(a) Anthracene on Hypothalamic Gonadotropin-Releasing Hormone and its Pituitary Receptor Gene Expression, During the Promotion Stage, in Female Sprague-Dawley Rats , 2002, Breast Cancer Research and Treatment.

[4]  S. Cos,et al.  Melatonin and Mammary Pathological Growth , 2000, Frontiers in Neuroendocrinology.

[5]  Y. Touitou,et al.  Progesterone inhibits, on a circadian basis, the release of melatonin by rat pineal perifusion , 2000, Steroids.

[6]  A. Amemiya,et al.  Melatonin secretion from organ-cultured pineal glands of rats: modulation by gonadectomy and gonadotropin-releasing hormone agonist administration. , 2000, European journal of endocrinology.

[7]  D. Blask,et al.  Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. , 1999, Cancer research.

[8]  S. Cos,et al.  Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. , 1999, Life sciences.

[9]  J. Vanecek.  Inhibitory effect of melatonin on GnRH-induced LH release. , 1999, Reviews of reproduction.

[10]  P. S. Lazo,et al.  Melatonin blocks the activation of estrogen receptor for DNA binding , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  S. Cos,et al.  Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. , 1998, Cancer research.

[12]  J. Alexander,et al.  A tumor-specific truncated estrogen receptor splice variant enhances estrogen-stimulated gene expression. , 1998, Molecular endocrinology.

[13]  R C Garner,et al.  The role of DNA adducts in chemical carcinogenesis. , 1998, Mutation research.

[14]  B. Kerdelhué,et al.  The in vitro effect of substance P on the GnRH-induced LH release depends on the steroidal environment and is reverted by a NK1 receptor antagonist (RP 67580) in the cycling female rat , 1998, Neuropeptides.

[15]  E. Cavalieri,et al.  Determination of benzo[a]pyrene- and 7,12-dimethylbenz[a]anthracene-DNA adducts formed in rat mammary glands. , 1997, Chemical research in toxicology.

[16]  R. Alonso,et al.  Ovarian hormones regulate alpha 1- and beta-adrenoceptor interactions in female rat pinealocytes. , 1995, Neuroreport.

[17]  S. Hill,et al.  Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. , 1994, Molecular endocrinology.

[18]  D. Cardinali,et al.  2-[125I]iodomelatonin binding sites in murine mammary tissue. , 1994, Biological signals.

[19]  R. Alonso,et al.  Progesterone does not mediate the inhibition of pineal melatonin production during the rat proestrous night , 1993, Neuroscience Letters.

[20]  L. Garcia-Segura,et al.  Estrogen-like effects of the mammary carcinogen 7,12-dimethylbenz(a)anthracene on hypothalamic neuronal membranes , 1992, Brain Research Bulletin.

[21]  W. McGuire,et al.  Estrogen receptor variants in clinical breast cancer. , 1991, Molecular endocrinology.

[22]  A Subramanian,et al.  Suppressive effect by melatonin on different phases of 9,10‐dimethyl-1,2‐benzanthracene (DMBA)-induced rat mammary gland carcinogenesis , 1991, Anti-cancer drugs.

[23]  H. Bartsch,et al.  Depression of serum melatonin in patients with primary breast cancer is not due to an increased peripheral metabolism , 1991, Cancer.

[24]  R. Alonso,et al.  Ovarian steroids block the isoproterenol-induced elevation of pineal melatonin production in the female rat , 1990, Neuroscience Letters.

[25]  C. Pasqualini,et al.  Estrogen-like effects of 7,12-dimethylbenz(a)anthracene on the female rat hypothalamo-pituitary axis. , 1990, Journal of steroid biochemistry.

[26]  H. Bartsch,et al.  Effect of the mammary carcinogen 7,12-dimethylbenz[a]anthracene on pineal melatonin biosynthesis, secretion and peripheral metabolism. , 1990, Neuroendocrinology.

[27]  H. Vaudry,et al.  Kinetic Study of Melatonin Release From Rat Pineal Glands Using a Perifusion Technique , 1989, Journal of pineal research.

[28]  J. Arendt,et al.  Entrainment of melatonin rhythms in rams by symmetrical light-dark cycles of different period length. , 1989, Chronobiology international.

[29]  S. Hill,et al.  Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. , 1988, Cancer research.

[30]  B. Kerdelhué,et al.  Stimulation of estradiol-17 beta secretion by 7,12-dimethylbenz (a) anthracene during mammary tumor induction in Sprague-Dawley rats. , 1987, Journal of steroid biochemistry.

[31]  Chawnshang Chang,et al.  Topographic recognition of cyclic hydrocarbons and related compounds by receptors for androgens, estrogens, and glucocorticoids. , 1987, Journal of steroid biochemistry.

[32]  D. Cardinali,et al.  Neuroendocrine integrative mechanisms in mammalian pineal gland: effects of steroid and adenohypophysial hormones on melatonin synthesis in vitro. , 1987, Journal of steroid biochemistry.

[33]  J. Russo,et al.  Susceptibility of the mammary gland to carcinogenesis. III. The cell of origin of rat mammary carcinoma. , 1983, The American journal of pathology.

[34]  M. Lippman,et al.  Melatonin increases oestrogen receptor binding activity of human breast cancer cells , 1983, Nature.

[35]  F. Daniel,et al.  DNA adduct formation by 7,12-dimethylbenz[a]anthracene and its noncarcinogenic 2-fluoro analogue in female Sprague-Dawley rats. , 1983, Journal of the National Cancer Institute.

[36]  M. Lippman,et al.  Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. , 1982, Science.

[37]  M. Cohen,et al.  Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. , 1981, Cancer research.

[38]  B. Kerdelhué,et al.  In vitro LHRH release: Correlation with the LH surge and alteration by a mammary carcinogen , 1981, Peptides.

[39]  R. Reiter.  The pineal and its hormones in the control of reproduction in mammals. , 1980, Endocrine reviews.

[40]  B. Kerdelhué,et al.  Inhibition of preovulatory gonadotropin secretion and stimulation of prolactin secretion by 7,12-dimethylbenz(a)anthracene in Sprague-Dawley rats. , 1979, Cancer research.

[41]  D. Cardinali.  Nuclear receptor estrogen complex in the pineal gland. Modulation by sympathetic nerves. , 1977, Neuroendocrinology.

[42]  T. Dao.  The role of ovarian hormones in initiating the induction of mammary cancer in rats by polynuclear hydrocarbons. , 1962, Cancer research.

[43]  C. Huggins,et al.  Mammary Cancer Induced by a Single Feeding of Polynuclear Hydrocarbons, and its Suppression , 1961, Nature.

[44]  N. Goodman.  New Research Laboratories of Hilger and Watts, Ltd. , 1961, Nature.